(5Z,8Z,11Z,14Z)-N-[(2R)-1-hydroxypropan-2-yl]-16,16-dimethyl-17-(morpholin-4-ylmethyl)nonadeca-5,8,11,14-tetraenamide

C29H50N2O3 — CID 71129515

IUPAC(5Z,8Z,11Z,14Z)-N-[(2R)-1-hydroxypropan-2-yl]-16,16-dimethyl-17-(morpholin-4-ylmethyl)nonadeca-5,8,11,14-tetraenamide
SMILESCCC(CN1CCOCC1)C(C)(C)/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)N[C@H](C)CO
InChIInChI=1S/C29H50N2O3/c1-5-27(24-31-20-22-34-23-21-31)29(3,4)19-17-15-13-11-9-7-6-8-10-12-14-16-18-28(33)30-26(2)25-32/h6-7,10-13,17,19,26-27,32H,5,8-9,14-16,18,20-25H2,1-4H3,(H,30,33)/b7-6-,12-10-,13-11-,19-17-/t26-,27?/m1/s1
InChIKeyFMDSGBWKBBJNHW-QJDJHNKOSA-N
MW474.73 g/mol
LogP5.43
Rot. Bonds17

About (5Z,8Z,11Z,14Z)-N-[(2R)-1-hydroxypropan-2-yl]-16,16-dimethyl-17-(morpholin-4-ylmethyl)nonadeca-5,8,11,14-tetraenamide

(5Z,8Z,11Z,14Z)-N-[(2R)-1-hydroxypropan-2-yl]-16,16-dimethyl-17-(morpholin-4-ylmethyl)nonadeca-5,8,11,14-tetraenamide (PubChem CID 71129515) has the molecular formula C29H50N2O3 and a molecular weight of 474.73 g/mol. Its IUPAC name is (5Z,8Z,11Z,14Z)-N-[(2R)-1-hydroxypropan-2-yl]-16,16-dimethyl-17-(morpholin-4-ylmethyl)nonadeca-5,8,11,14-tetraenamide.

Molecular Properties

Compound Name(5Z,8Z,11Z,14Z)-N-[(2R)-1-hydroxypropan-2-yl]-16,16-dimethyl-17-(morpholin-4-ylmethyl)nonadeca-5,8,11,14-tetraenamide
PubChem CID71129515
Molecular FormulaC29H50N2O3
Molecular Weight474.73 g/mol
Exact Mass474.38
IUPAC Name(5Z,8Z,11Z,14Z)-N-[(2R)-1-hydroxypropan-2-yl]-16,16-dimethyl-17-(morpholin-4-ylmethyl)nonadeca-5,8,11,14-tetraenamide
SMILESCCC(CN1CCOCC1)C(C)(C)/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)N[C@H](C)CO
InChIInChI=1S/C29H50N2O3/c1-5-27(24-31-20-22-34-23-21-31)29(3,4)19-17-15-13-11-9-7-6-8-10-12-14-16-18-28(33)30-26(2)25-32/h6-7,10-13,17,19,26-27,32H,5,8-9,14-16,18,20-25H2,1-4H3,(H,30,33)/b7-6-,12-10-,13-11-,19-17-/t26-,27?/m1/s1
InChIKeyFMDSGBWKBBJNHW-QJDJHNKOSA-N
XLogP5.43
TPSA61.80 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds17
Heavy Atoms34
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500474.73
LogP ≤ 55.43
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (5Z,8Z,11Z,14Z)-N-[(2R)-1-hydroxypropan-2-yl]-16,16-dimethyl-17-(morpholin-4-ylmethyl)nonadeca-5,8,11,14-tetraenamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (5Z,8Z,11Z,14Z)-N-[(2R)-1-hydroxypropan-2-yl]-16,16-dimethyl-17-(morpholin-4-ylmethyl)nonadeca-5,8,11,14-tetraenamide?
The IUPAC name of (5Z,8Z,11Z,14Z)-N-[(2R)-1-hydroxypropan-2-yl]-16,16-dimethyl-17-(morpholin-4-ylmethyl)nonadeca-5,8,11,14-tetraenamide (CID 71129515) is (5Z,8Z,11Z,14Z)-N-[(2R)-1-hydroxypropan-2-yl]-16,16-dimethyl-17-(morpholin-4-ylmethyl)nonadeca-5,8,11,14-tetraenamide.
What is the SMILES notation for (5Z,8Z,11Z,14Z)-N-[(2R)-1-hydroxypropan-2-yl]-16,16-dimethyl-17-(morpholin-4-ylmethyl)nonadeca-5,8,11,14-tetraenamide?
The canonical SMILES for (5Z,8Z,11Z,14Z)-N-[(2R)-1-hydroxypropan-2-yl]-16,16-dimethyl-17-(morpholin-4-ylmethyl)nonadeca-5,8,11,14-tetraenamide is CCC(CN1CCOCC1)C(C)(C)/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)N[C@H](C)CO.
What is the InChIKey of (5Z,8Z,11Z,14Z)-N-[(2R)-1-hydroxypropan-2-yl]-16,16-dimethyl-17-(morpholin-4-ylmethyl)nonadeca-5,8,11,14-tetraenamide?
The InChIKey is FMDSGBWKBBJNHW-QJDJHNKOSA-N. The full InChI is InChI=1S/C29H50N2O3/c1-5-27(24-31-20-22-34-23-21-31)29(3,4)19-17-15-13-11-9-7-6-8-10-12-14-16-18-28(33)30-26(2)25-32/h6-7,10-13,17,19,26-27,32H,5,8-9,14-16,18,20-25H2,1-4H3,(H,30,33)/b7-6-,12-10-,13-11-,19-17-/t26-,27?/m1/s1.
What are the key properties of (5Z,8Z,11Z,14Z)-N-[(2R)-1-hydroxypropan-2-yl]-16,16-dimethyl-17-(morpholin-4-ylmethyl)nonadeca-5,8,11,14-tetraenamide?
(5Z,8Z,11Z,14Z)-N-[(2R)-1-hydroxypropan-2-yl]-16,16-dimethyl-17-(morpholin-4-ylmethyl)nonadeca-5,8,11,14-tetraenamide has a molecular weight of 474.73 g/mol, XLogP of 5.43, 17 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for (5Z,8Z,11Z,14Z)-N-[(2R)-1-hydroxypropan-2-yl]-16,16-dimethyl-17-(morpholin-4-ylmethyl)nonadeca-5,8,11,14-tetraenamide is sourced from PubChem (CID 71129515), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).